{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:11:02Z","timestamp":1790291462270,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002086","name":"Fanconi Anemia Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.exphem.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:53:24Z","timestamp":1604703204000},"page":"70-84.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Inhibition of TGF\u03b21 and TGF\u03b23 promotes hematopoiesis in Fanconi anemia"],"prefix":"10.1016","volume":"93","author":[{"given":"Alfredo","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-1007","authenticated-orcid":false,"given":"Benilde","family":"Garc\u00eda de Teresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-4949","authenticated-orcid":false,"given":"Jessica","family":"Filiatrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Sambel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-0874","authenticated-orcid":false,"given":"Patricia","family":"Flores-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-0907","authenticated-orcid":false,"given":"Silvia","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Monsiv\u00e1is Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Mayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-6343","authenticated-orcid":false,"given":"Ozge V.","family":"Bolukbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"F\u00e4rkkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4683-9958","authenticated-orcid":false,"given":"Akiko","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-6368","authenticated-orcid":false,"given":"Sara","family":"Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalindi","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2020.11.002_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2020.11.002_bib0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","article-title":"The Fanconi anaemia pathway: new players and new functions","volume":"17","author":"Ceccaldi","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2004.05023.x","article-title":"Fanconi anaemia and leukaemia\u2014Clinical and molecular aspects","volume":"126","author":"Tischkowitz","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2020.11.002_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2013-09-427740","article-title":"Why does the bone marrow fail in Fanconi anemia?","volume":"123","author":"Garaycoechea","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.002_bib0006","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.hoc.2018.04.002","article-title":"Myelodysplastic syndrome, acute myeloid leukemia, and cancer surveillance in Fanconi anemia","volume":"32","author":"Savage","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2020.11.002_bib0007","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjh.14535","article-title":"The genomics of inherited bone marrow failure: from mechanism to the clinic","volume":"177","author":"Wegman-Ostrosky","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0008","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1172\/JCI92069","article-title":"Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia","volume":"127","author":"Knies","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2020.11.002_bib0009","doi-asserted-by":"crossref","first-page":"R986","DOI":"10.1016\/j.cub.2017.07.043","article-title":"Fanconi anemia pathway","volume":"27","author":"Rodriguez","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012732","article-title":"Advances in understanding the complex mechanisms of DNA interstrand cross-link repair","volume":"5","author":"Clauson","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0011","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature11863","article-title":"Fanconi anaemia and the repair of Watson and Crick DNA crosslinks","volume":"493","author":"Kottemann","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0012","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in Fanconi's anemia and breast cancer","volume":"362","author":"D'Andrea","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.11.002_bib0013","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.stem.2016.03.002","article-title":"TGF-beta inhibition rescues hematopoietic stem cell defects and bone marrow failure in Fanconi anemia","volume":"18","author":"Zhang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2020.11.002_bib0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/dev.111.1.131","article-title":"Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo","volume":"111","author":"Millan","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.exphem.2020.11.002_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tibs.2010.08.002","article-title":"TGFbeta: a sleeping giant awoken by integrins","volume":"36","author":"Worthington","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.exphem.2020.11.002_bib0016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1165\/ajrcmb.14.2.8630262","article-title":"TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study","volume":"14","author":"Khalil","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","article-title":"Induction of epithelial\u2013mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis","volume":"166","author":"Willis","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0018","first-page":"5","article-title":"Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-beta","volume":"3","author":"Agarwal","year":"2016","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.exphem.2020.11.002_bib0019","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood-2004-04-1320","article-title":"A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis","volume":"105","author":"Vannucchi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.002_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1756-8722-6-50","article-title":"Signal transduction inhibitors in treatment of myelodysplastic syndromes","volume":"6","author":"Bachegowda","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exphem.2017.12.010","article-title":"Megakaryocyte-derived excessive transforming growth factor beta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia","volume":"60","author":"Gong","year":"2018","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGFbeta action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0023","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","article-title":"TGF-beta receptor inhibitors target the CD44(high)\/Id1(high) glioma-initiating cell population in human glioblastoma","volume":"18","author":"Anido","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2020.11.002_bib0024","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0025","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/ncomms15021","article-title":"FAF1 phosphorylation by AKT accumulates TGF-beta type II receptor and drives breast cancer metastasis","volume":"8","author":"Xie","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2020.11.002_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/noq142","article-title":"Targeted therapy for high-grade glioma with the TGF-beta2 inhibitor trabedersen: results of a randomized and controlled phase IIb study","volume":"13","author":"Bogdahn","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0027","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00280-017-3313-x","article-title":"Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer","volume":"79","author":"Ikeda","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0028","first-page":"4479","article-title":"Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.exphem.2020.11.002_bib0029","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2352-3026(18)30002-4","article-title":"Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial","volume":"5","author":"Komrokji","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.11.002_bib0031","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ijc.31331","article-title":"Immune checkpoint blockade combined with IL-6 and TGF-beta inhibition improves the therapeutic outcome of mRNA-based immunotherapy","volume":"143","author":"Bialkowski","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2020.11.002_bib0032","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0033","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/1078-0432.CCR-17-2653","article-title":"Phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGFbeta, in advanced solid tumors","volume":"24","author":"Strauss","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2020.11.002_bib0034","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood-2016-05-718320","article-title":"TGF-beta inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors","volume":"128","author":"Gao","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha\/beta signalling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0036","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20030980","article-title":"Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function","volume":"199","author":"Langer","year":"2004","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2020.11.002_bib0037","first-page":"2532","article-title":"AVID200: A novel TGF-\u03b2 inhibitor for the treatment of anemia associated with myelodysplastic syndromes","volume":"130","author":"Thwaites","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.002_bib0038","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1172\/JCI125375","article-title":"TGFbeta signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman\u2013Diamond syndrome","volume":"129","author":"Joyce","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2020.11.002_bib0039","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature25154","article-title":"Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells","volume":"553","author":"Garaycoechea","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2010.06.026","article-title":"Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia","volume":"39","author":"Adamo","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2020.11.002_bib0042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.1192277","article-title":"Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway","volume":"329","author":"Pace","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.11.002_bib0043","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature14131","article-title":"Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells","volume":"520","author":"Walter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0044","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature14184","article-title":"Homologous-recombination-deficient tumours are dependent on Poltheta-mediated repair","volume":"518","author":"Ceccaldi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0045","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.1074\/jbc.TM117.000375","article-title":"Repair of DNA double-strand breaks by mammalian alternative end-joining pathways","volume":"293","author":"Sallmyr","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2020.11.002_bib0046","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-018-0362-1","article-title":"53BP1 cooperation with the REV7\u2013shieldin complex underpins DNA structure-specific NHEJ","volume":"560","author":"Ghezraoui","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0047","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","article-title":"The shieldin complex mediates 53BP1-dependent DNA repair","volume":"560","author":"Noordermeer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0048","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41556-018-0140-1","article-title":"Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells","volume":"20","author":"Dev","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2020.11.002_bib0049","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2020.11.002_bib0050","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/01.CIR.103.22.2745","article-title":"Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-\u03b22-knockout mice","volume":"103","author":"Bartram","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.exphem.2020.11.002_bib0051","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.002_bib0052","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0192623311416259","article-title":"Induction of heart valve lesions by small-molecule ALK5 inhibitors","volume":"39","author":"Anderton","year":"2011","journal-title":"Toxicol Pathol"},{"issue":"341","key":"10.1016\/j.exphem.2020.11.002_bib0053","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/scisignal.2005474","article-title":"New tricks for an old fox: impact of TGFbeta on the DNA damage response and genomic stability","volume":"7","author":"Barcellos-Hoff","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.exphem.2020.11.002_bib0054","doi-asserted-by":"crossref","first-page":"e21615","DOI":"10.7554\/eLife.21615","article-title":"TGF-\u03b2 reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+\/CD24\u2013 cancer cells","volume":"6","author":"Pal","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.exphem.2020.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/emboj\/21.5.1219","article-title":"Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair","volume":"21","author":"Kanamoto","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2020.11.002_bib0056","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nsmb.3083","article-title":"Control of telomerase action at human telomeres","volume":"22","author":"Hockemeyer","year":"2015","journal-title":"Nat Struct Mol Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20306202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20306202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:36:34Z","timestamp":1759566994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X20306202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":56,"alternative-id":["S0301472X20306202"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2020.11.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TGF\u03b21 and TGF\u03b23 promotes hematopoiesis in Fanconi anemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}